Scientists are leveraging HIV research to train T cells, transforming them into an army that seeks out and destroys cancer cells. Hear more about this breakthrough that could revolutionize immunotherapy from Umoja Biopharma’s CEO and CFO in a new “For Your Innovation.”

Similar Posts